New HIV Research Findings to Be Presented at NAPWA "Treatment Horizons: Pathways to a Functional Cure" Satellite Symposium, International AIDS Society, Rome
July 15, 2011 07:30 ET | National Association of People with AIDS
SILVER SPRING, MD and ROME--(Marketwire - Jul 15, 2011) - HIV researchers working towards developing potential functional cures from three continents will present new data that collectively light a...
"Next Generation" HIV/AIDS Treatments Featured in NAPWA and The AIDS Institute's Community Forum at XVIII International AIDS Conference
July 22, 2010 11:07 ET | National Association of People with AIDS
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) -  New data presented by researchers at the XVIII International AIDS Conference this week shows significant momentum for the emerging field of...
"Research Advances from Therapeutic HIV Vaccines and Other Immune-Based Therapies" to Be Showcased at NAPWA Sponsored Community Treatment Research Forum at XVIII World AIDS Conference
July 13, 2010 13:45 ET | National Association of People with AIDS
SILVER SPRING, MD--(Marketwire - July 13, 2010) -  The National Association of People with AIDS today announced that it is hosting a Community Treatment Research Forum, "Research Advances from...
GlobeImmune's Hepatitis C Product Candidate Improves End of Treatment Response in All IL-28 B Genotypes, With the Greatest Effect in the Hardest-to-Treat Patients
April 19, 2010 07:00 ET | GlobeImmune
LOUISVILLE, CO--(Marketwire - April 19, 2010) -  GlobeImmune Inc. announced Phase 2b data for GI-5005, the Company's investigational Tarmogen® product for hepatitis C virus (HCV) infection,...
GlobeImmune GI-5005 HCV Product Candidate Improves Sustained Virologic Response by 10 Percent, Demonstrating Potential to Be First Therapeutic Vaccine for HCV
April 15, 2010 13:00 ET | GlobeImmune
LOUISVILLE, CO--(Marketwire - April 15, 2010) -  GlobeImmune, Inc. today announced final Phase 2b data for GI-5005, the Company's investigational Tarmogen® product candidate, demonstrating...